Cargando…
Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
Autores principales: | Wang, Yuxiang, Li, Xian, Liu, Xueling, Chen, Yi, Yang, Chunhao, Tan, Cun, Wang, Bobo, Sun, Yiming, Zhang, Xi, Gao, Yinglei, Ding, Jian, Meng, Linghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936228/ https://www.ncbi.nlm.nih.gov/pubmed/31908900 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0401 |
Ejemplares similares
-
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
por: Wang, Yuxiang, et al.
Publicado: (2019) -
Erratum to CDK14 involvement in proliferation migration and invasion of esophageal cancer
por: Chen, Lingling, et al.
Publicado: (2020) -
Erratum to: Synergistic anti-malarial action of cryptolepine and artemisinins
por: Forkuo, Arnold D., et al.
Publicado: (2016) -
Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022) -
ERRATUM: CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2014)